Literature DB >> 19639500

Association of polycystic ovary syndrome with cardiovascular risk factors.

Tanzeela Akram1, Shahid Hasan, Muhammad Imran, Asima Karim, Muhammad Arslan.   

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS), also clinically known as Stein-Leventhal syndrome, is an endocrine disorder that affects 5-10% of women.
OBJECTIVE: To evaluate the risk factors for developing early onset of cardiovascular disease (CVD) in young patients with PCOS from our local population.
DESIGN: Case-control study.
METHODS: Fifty women with PCOS selected by history and transvaginal ultrasounds and 30 age-matched healthy women (controls). The case subjects and controls were further divided into two age categories comprising of equal number of subjects, of 20-29 and 30-39 years of age. The subjects underwent a detailed medical history, general physical examination, systolic (SBP) and diastolic blood pressures (DBP). Fasting blood samples were analyzed for glucose, insulin, triacylglycerides (TAG), total cholesterol, high density lipoprotein-C (HDL-C), low density lipoprotein-C (LDL-C), follicle-stimulating hormone (FSH), and luteinizing hormone (LH).
RESULTS: Women with the PCOS had significantly higher mean arterial pressure (MAP), serum TAG, LDL-C, insulin, and LH levels when compared with the age-matched control subjects. No significant differences were observed between serum cholesterol, glucose, and FSH levels between cases and controls. However, no marked differences were observed in biochemical parameters between the two age groups of PCOS patients.
CONCLUSIONS: Younger women with PCOS are equally at risk of developing CVD as older women.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19639500     DOI: 10.3109/09513590903159565

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  5 in total

1.  Cholesterol, endocrine and metabolic disturbances in sporadic anovulatory women with regular menstruation.

Authors:  Sunni L Mumford; Enrique F Schisterman; Anna Maria Siega-Riz; Audrey J Gaskins; Anne Z Steiner; Julie L Daniels; Andrew F Olshan; Mary L Hediger; Kathleen Hovey; Jean Wactawski-Wende; Maurizio Trevisan; Michael S Bloom
Journal:  Hum Reprod       Date:  2010-11-28       Impact factor: 6.918

2.  Cardiovascular Risk According to Body Mass Index in Women of Reproductive Age With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Chenchen Zhuang; Xufei Luo; Wenjuan Wang; Runmin Sun; Miaomiao Qi; Jing Yu
Journal:  Front Cardiovasc Med       Date:  2022-02-16

3.  Commentary: Cardiovascular risk according to body mass index in women of reproductive age with polycystic ovary syndrome: A systematic review and meta-analysis.

Authors:  Yani Ke; Kaihan Wu; Shan Liu
Journal:  Front Cardiovasc Med       Date:  2022-08-10

Review 4.  Impact of metformin on the clinical and metabolic parameters of women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Mohammed Altigani Abdalla; Najeeb Shah; Harshal Deshmukh; Amirhossein Sahebkar; Linda Östlundh; Rami H Al-Rifai; Stephen L Atkin; Thozhukat Sathyapalan
Journal:  Ther Adv Endocrinol Metab       Date:  2022-10-07       Impact factor: 4.435

Review 5.  Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility.

Authors:  Valeria Calcaterra; Elvira Verduci; Hellas Cena; Vittoria Carlotta Magenes; Carolina Federica Todisco; Elisavietta Tenuta; Cristina Gregorio; Rachele De Giuseppe; Alessandra Bosetti; Elisabetta Di Profio; Gianvincenzo Zuccotti
Journal:  Nutrients       Date:  2021-05-28       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.